Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
25.70
+0.56 (2.23%)
Aug 29, 2025, 4:00 PM - Market closed
Fresenius Medical Care AG Revenue
Fresenius Medical Care AG had revenue of 4.79B EUR in the quarter ending June 30, 2025, with 0.53% growth. This brings the company's revenue in the last twelve months to 19.52B, up 0.53% year-over-year. In the year 2024, Fresenius Medical Care AG had annual revenue of 19.34B, down -0.61%.
Revenue (ttm)
19.52B EUR
Revenue Growth
+0.53%
P/S Ratio
0.65
Revenue / Employee
175,030 EUR
Employees
111,513
Market Cap
14.95B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.34B | -117.71M | -0.61% |
| Dec 31, 2023 | 19.45B | 55.60M | 0.29% |
| Dec 31, 2022 | 19.40B | 1.78B | 10.10% |
| Dec 31, 2021 | 17.62B | -240.38M | -1.35% |
| Dec 31, 2020 | 17.86B | 382.51M | 2.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
FMS News
- 20 days ago - Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework - PRNewsWire
- 25 days ago - Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025 - PRNewsWire
- 5 weeks ago - Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy) - Seeking Alpha
- 6 weeks ago - $6.3 Trillion Outpatient Clinics Markets, 2021-2024 & 2025-2029 | Profiles of Leading Players - Johns Hopkins Medicine, Mayo Clinic, MD Anderson Cancer Center, Apollo Hospital, and Fresenius Medical - GlobeNewsWire
- 2 months ago - Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico - PRNewsWire
- 2 months ago - Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency - Benzinga
- 2 months ago - Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs - WSJ